R0 resection status serves as the principal prognostic determinant for oncological outcomes in re-recurrent rectal cancer
Surgery for Recurrent Rectal Cancer Shows Mixed Outcomes
This systematic review of retrospective cohort studies examines perioperative management and outcomes for patients with re-recurrent rectal …
New data shows that curative intent surgery for recurrent rectal cancer is possible for some patients, but results vary based on surgical ma…
ctDNA and immune profiling offer a pathway toward individualized treatment for recurrent colorectal cancer
New tools help identify high risk of colorectal cancer relapse
This mini review explores ctDNA-guided surveillance, immune checkpoint blockade, and engineered cell therapies for patients with colorectal …
Doctors are using blood tests and immune profiling to better predict when colorectal cancer might return after treatment.
First-line immune checkpoint inhibitor therapy improves progression-free survival and overall survival in MSI-H/dMMR mCRC
Immune checkpoint inhibitors improve survival for certain colorectal cancers
This meta-analysis of more than 600 patients with metastatic colorectal cancer (mCRC) involving microsatellite instability-high or mismatch …
New analysis shows immune checkpoint inhibitors offer better survival and fewer side effects than chemotherapy for specific types of metasta…
Immune checkpoint inhibitor regimens for colorectal cancer increase risk of endocrine adverse events
Immunotherapy for colon cancer linked to thyroid problems
This network meta-analysis evaluates endocrine toxicity in patients with colorectal cancer treated with immune checkpoint inhibitor (ICI) ba…
New analysis finds immunotherapy for colorectal cancer raises risk of thyroid issues, especially with certain drug combos.
Robustly generalizable gut microbiome signatures are identified in patients with colorectal cancer regardless of age
Gut bacteria patterns show consistent signs of colorectal cancer
This meta-analysis of 27 studies involving 6779 samples identified consistent gut microbiome signatures in patients with colorectal cancer. …
New data shows that specific gut bacteria can signal colorectal cancer regardless of a person's age or the type of testing used.
High tumour-associated neutrophils at the invasive margin are associated with improved overall survival
Neutrophils at Tumor Edge Linked to Better Colon Cancer Survival
This meta-analysis of 7,406 patients with stages I-IV colorectal cancer found that high tumour-associated neutrophils (TANs) at the invasive…
A new meta-analysis finds that high levels of certain immune cells at the tumor's edge are linked to better survival in colorectal cancer pa…
Enhanced communication using behavioral economics principles did not significantly increase FIT test completion rates
Enhanced messaging shows modest increase in colon cancer screening rates
This randomized trial involving 4,070 Medicare patients at average-risk for colon cancer found that enhanced communication incorporating beh…
New research looks at how special communication techniques can help more people complete their colorectal cancer screenings.
Antibiotic exposure is associated with an 18.7% higher risk of gastrointestinal cancers
Antibiotic use linked to higher risk of gastrointestinal cancers
This meta-analysis of 12 studies indicates that antibiotic use is associated with a statistically significant increase in the risk of gastro…
New data shows a link between taking antibiotics and an increased risk of developing certain gastrointestinal cancers like colorectal cancer…
Gut microbiome biomarkers show AUROC of 0.89 for differentiating colorectal cancer from controls
Gut Microbiome Biomarkers Show Promise for Detecting Colorectal Cancer
This meta-analysis of 27 studies evaluates the diagnostic performance of gut-based biomarkers in patients with colorectal cancer and adenoma…
Specific bacteria in the gut may help identify colorectal cancer and precancerous growths, though age differences can affect how accurate th…
Sugar sweetened beverages and orange juice are associated with increased risk of several cancer types
Sugar sweetened drinks may increase risk of several cancer types
This meta-analysis of 51 cohort studies evaluates the link between sugar sweetened beverages (SSBs), artificially sweetened beverages (ASBs)…
New research suggests a link between sugar-sweetened beverages and an increased risk of certain cancers, including pancreatic and colorectal…
Intraoperative indocyanine green fluorescence angiography improves bowel perfusion assessment in colorectal anastomosis surgery
New standards aim to improve blood flow monitoring in colorectal surgery
This clinical guideline focuses on standardizing the acquisition and reporting of intraoperative indocyanine green fluorescence angiography …
Doctors are establishing new rules for using special dyes to better track blood flow during complex colon and rectal surgeries.
Preoperative inflammatory and nutritional markers are associated with increased postoperative pulmonary risk in gastrointestinal cancers
Inflammatory and Nutritional Markers Linked to Lung Risks After Surgery
This systematic review and narrative synthesis examines the association between preoperative biomarkers and postoperative pulmonary complica…
Poor nutrition and high inflammation levels before surgery may increase the risk of lung complications for patients with gastric or colorect…
Questions about Colorectal Cancer
Is robotic surgery safe for treating colorectal cancer and liver metastases together?
Yes, robotic surgery appears safe for treating colorectal cancer and liver metastases together in selected patients, with low conversion rates and no reported deaths in early studies.
Full answer →How do specific mutations affect treatment response in Colorectal Cancer?
Specific mutations like KRAS, BRAF, and MMR status strongly influence treatment response in colorectal cancer, guiding targeted therapy and immunotherapy decisions.
Full answer →What factors affect the quality of life for survivors of Colorectal Cancer?
Quality of life for colorectal cancer survivors is influenced by physical symptoms, psychological distress, social support, self-efficacy, and demographic factors like age and gender.
Full answer →How does gut microbiota relate to the development of Colorectal Cancer?
Gut microbiota imbalances, including harmful bacteria like Fusobacterium nucleatum, can promote colorectal cancer through inflammation, DNA damage, and immune disruption, while beneficial microbes may offer protection.
Full answer →What are the challenges of using artificial intelligence for Colorectal Cancer treatment?
AI in colorectal cancer treatment faces challenges including data quality and privacy issues, lack of generalizability, interpretability problems, and regulatory validation hurdles.
Full answer →Can home exercise help reduce fatigue and anxiety in Colorectal Cancer patients?
Yes, home exercise may help reduce fatigue and anxiety in colorectal cancer patients, but the evidence is low certainty and more research is needed.
Full answer →All Colorectal Cancer Articles
- R0 resection status serves as the principal prognostic determinant for oncological outcomes in re-recurrent rectal cancer
- ctDNA and immune profiling offer a pathway toward individualized treatment for recurrent colorectal cancer
- First-line immune checkpoint inhibitor therapy improves progression-free survival and overall survival in MSI-H/dMMR mCRC
- Immune checkpoint inhibitor regimens for colorectal cancer increase risk of endocrine adverse events
- Robustly generalizable gut microbiome signatures are identified in patients with colorectal cancer regardless of age
- High tumour-associated neutrophils at the invasive margin are associated with improved overall survival
- Enhanced communication using behavioral economics principles did not significantly increase FIT test completion rates
- Sugar sweetened beverages and orange juice are associated with increased risk of several cancer types
- Intraoperative indocyanine green fluorescence angiography improves bowel perfusion assessment in colorectal anastomosis surgery
- Antibiotic exposure is associated with an 18.7% higher risk of gastrointestinal cancers
- Gut microbiome biomarkers show AUROC of 0.89 for differentiating colorectal cancer from controls
- Preoperative inflammatory and nutritional markers are associated with increased postoperative pulmonary risk in gastrointestinal cancers
- Traditional Chinese medicine may modulate immune resistance barriers in microsatellite-stable colorectal cancer
- Twenty-two factors across five ecological levels are significantly associated with fear of cancer recurrence
- Persistent descending mesocolon increases operative time and conversion rates in colorectal cancer surgery
- Multiple clinical and perioperative factors are significantly associated with postoperative abdominal infection in colorectal cancer patients
- Nanomedicine delivery systems may enhance immunotherapy efficacy in colorectal cancer
- Mendelian Randomization Evaluates IL-6 Inhibition Effects on Hepatocellular and Colorectal Cancer Risk
- Enteral immunonutrition reduces infectious complications in patients undergoing surgery for colorectal cancer
- Epigallocatechin-3-gallate shows positive therapeutic effects on various digestive system diseases in animal models
- Artificial intelligence as a mechanistic microscope and digital twin in colorectal cancer faces generalizability and regulatory validation limitations
- Screening and management strategies for stigma in patients with colorectal cancer and stomas require clinically meaningful guidance
- Oxaliplatin addition to rectal cancer chemoradiation improves tumor regression
- Systematic review shows robotic colorectal surgery lowers CRP and complications versus laparoscopy in adult patients
- Robotic TME reduces CRM positivity and three-year recurrence in mid or low rectal cancer
- Fecal DNA testing improved colorectal cancer screening rates compared to immunochemical testing in primary care
- Metabolic syndrome linked to higher risk of several obesity-related cancers and worse colorectal cancer survival
- 27648 patients shows robotic TME improves specimen quality and margin safety for rectal cancer cases
- Microbiome and metabolite markers may enhance colorectal cancer detection and therapeutic guidance strategies
- Narrative review links gut microbial metabolites to colorectal cancer mechanisms
- Multicomponent intervention with mailed FIT and navigation increased colorectal cancer screening uptake in Federally Qualified Health Centers
- PD-1/PD-L1 inhibitors improve response in dMMR/MSI-H metastatic colorectal cancer
- Narrative review discusses colorectal cancer metastasis patterns with immune checkpoint inhibitors and targeted therapies
- Postoperative exercise interventions shorten intestinal recovery time in colorectal cancer surgery
- Narrative review on immune microenvironment evolution in serrated neoplasia and colorectal cancer
- Review examines mRNA vaccines versus traditional platforms for colorectal cancer
- Meta-analysis of home-based exercise for colorectal cancer reports reduced anxiety and fatigue with low certainty evidence
- Review of gut microbiota and colorectal cancer highlights unresolved causality and clinical translation challenges
- Narrative review covers hepatocellular carcinoma, colorectal cancer, glioblastoma, breast cancer, pancreatic cancer, and non-small cell lung cancer
- Tislelizumab plus chemotherapy and radiotherapy yields 89.1% 3-year disease-free survival in pMMR/MSS locally advanced rectal cancer
- Avelumab plus cetuximab versus cetuximab alone in metastatic colorectal cancer patients
- TaTME shows lower conversion rates with similar short-term safety compared to LapTME for low rectal cancer
- Educational programs improve self-care values in ostomized colorectal cancer patients
- Systematic review and meta-analysis identifies factors influencing quality of life in colorectal cancer survivors
- Narrative review explores colorectal cancer mutations and tumor microenvironment interactions for TASIN-1
- Neoadjuvant mFOLFOXIRI plus bevacizumab reduces peritoneal tumor burden in colorectal cancer patients
- Systematic review and meta-analysis of robotic versus laparoscopic surgery for rectal cancer
- Narrative review suggests CXCR4 antagonists may target metastatic colorectal cancer via the CXCL12/CXCR4 axis
- Modified Banxia Xiexin Decoction plus chemotherapy shows favorable trends in advanced colorectal cancer
- Colonoscopic Surveillance in Lynch Syndrome Linked to Lower Mortality but Not Reduced Cancer Incidence
- Review of combination strategies for digestive system tumors including gastric and colorectal cancer
- Electroacupuncture Shortens Time to First Defecation in Colorectal Cancer Surgery Patients
- Thunder-fire moxibustion may reduce fatigue in colorectal cancer patients undergoing chemotherapy
- Tumor debulking plus chemotherapy did not improve overall survival in multiorgan metastatic colorectal cancer patients
- Perioperative Propranolol and Etodolac Safety and 8-Year Survival in Cancer Patients
- SCOPE platform predicts outcomes for metastatic colorectal and pancreatic cancers using organoid screening
- Narrative review examines ulcerative colitis and colorectal cancer risk
- Meta-analysis of 7,750 saliva samples validates non-invasive disease prediction models for nasopharyngeal carcinoma, colorectal cancer, and PLHIV
- Sequential cetuximab-bevacizumab vs bevacizumab-EGFR mAb shows no DDC difference in metastatic CRC
- Aspirin and NSAIDs show little benefit for colorectal cancer prevention within 15 years but increase bleeding risk
- Robotic simultaneous resection for synchronous colorectal cancer and liver metastases shows feasibility and safety in a meta-analysis
- Network meta-analysis shows image-enhanced endoscopy methods improve adenoma detection rates compared to high-definition white light imaging in colorectal lesion screening
- Neoadjuvant CAPOX chemotherapy alone showed comparable survival to chemoradiotherapy in locally advanced rectal cancer with uninvolved mesorectal fascia
- Trifluridine/tipiracil plus irinotecan and bevacizumab in metastatic colorectal cancer resistant to prior chemotherapy
- Immunonutrition supplementation significantly shortened time to first flatus in colorectal cancer surgery patients
- Cognitive-behavioral sleep intervention with nutritional support improves sleep, survival in rectal cancer surgery patients
- Intratumoral H101 plus total neoadjuvant therapy yields pathologic complete response in one patient with metachronous locally advanced rectal cancer
- Network meta-analysis ranks exercise types for colorectal cancer survivors post-resection based on specific outcomes
- Meta-analysis links higher BMI to increased early-onset colorectal cancer risk
- Dynamic ctDNA monitoring during neoadjuvant chemotherapy identifies high-risk rectal cancer patients
- Prehabilitation improves functional capacity and reduces severe complications in elective colorectal cancer surgery
- Nurse-led music intervention shows preliminary benefit for cognitive impairment in colorectal cancer patients
- Computational framework reconstructs multidimensional clinical profiles from published Kaplan-Meier images